Skip to search formSkip to main contentSkip to account menu

romifidine

Known as: N-(2-bromo-6-fluorophenyl)-4,5-dihydro-(1H)-imidazol-2-amine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
OBJECTIVE To evaluate the effects of a constant rate infusion (CRI) of romifidine on the requirement of isoflurane… 
Highly Cited
2010
Highly Cited
2010
A technique of transrectal ultrasonography was developed to investigate the effects of romifidine 80 and 120 microg/kg bwt on… 
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate and compare the antinociceptive effects of the three alpha-2 agonists, detomidine, romifidine and xylazine… 
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To study the analgesic potency of the alpha2-agonist romifidine in the horse using both an electrical current and a… 
Highly Cited
1997
Highly Cited
1997
In the present study, the hypoxaemic potential of four alpha 2 agonists possessing different selectivity for alpha 2… 
Highly Cited
1996
Highly Cited
1996
The purpose of this study was to compare and evaluate sedation with intravenous xylazine (1.1 mg/kg bodyweight [BW]) versus… 
Highly Cited
1995
Highly Cited
1995
In a double blind study, eight horses were treated intravenously at seven-day intervals with detomidine at doses of 10, 20 and 40… 
Highly Cited
1992
Highly Cited
1992
The sedative effects of a new alpha 2-adrenoceptor agonist, romifidine, were compared with those of xylazine and detomidine. Five… 
Highly Cited
1991
Highly Cited
1991
SUMMARY The behavioural and sedative effects of intravenous (iv) romifidine (40 and 80 μg/kg bodyweight [bwt]) alone or in…